VUL

Vulcan Two Group PLC

Personal Care, Drug and Grocery Stores First-pass screen £63m

250/1000 Overall fit

AI beneficiary 35% 20

Operating leverage 25% 20

Valuation 25% 30

Downside protection 15% 35

First-pass take

Pre-revenue acquisition vehicle seeking ePharmacy targets. No demonstrated AI/ML exposure or operating leverage. Management assembled £12m from September 2025 IPO, but execution risk on acquisitions is material. Balance sheet cleaned via debt-to-equity conversion post-period signals prior stress.

Flags

loss-makingpre-revenueshell-companybalance-sheet-engineeringexecution-dependentmicro-cap